Balance Sheet
Cash Flow Statement
Daily Values
DMA 100DMA 200DMA 50Dividend YieldEV to CFOEV to EBITEV to EBITDAEV to FCFEV to RevenueEnterprise ValueMarket Cap to FCFMarket CapitalizationPricePrice to EarningsPrice to Sales
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

INVO Fertility (IVF) Enterprise Value (2024 - 2026)

INVO Fertility has reported Enterprise Value over the past 16 years, most recently at -$355891.0 for Q3 2025.

  • Quarterly Enterprise Value rose 28.82% to -$355891.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was -$355891.0 through Sep 2025, up 28.82% year-over-year, with the annual reading at -$741396.0 for FY2024, 218.98% down from the prior year.
  • Enterprise Value was -$355891.0 for Q3 2025 at INVO Fertility, up from -$500000.0 in the prior quarter.
  • Over five years, Enterprise Value peaked at -$90135.0 in Q4 2022 and troughed at -$8.4 million in Q1 2021.
  • The 5-year median for Enterprise Value is -$840407.0 (2025), against an average of -$2.1 million.
  • Year-over-year, Enterprise Value plummeted 2306.64% in 2021 and then surged 98.41% in 2022.
  • A 5-year view of Enterprise Value shows it stood at -$5.7 million in 2021, then surged by 98.41% to -$90135.0 in 2022, then tumbled by 157.86% to -$232424.0 in 2023, then tumbled by 218.98% to -$741396.0 in 2024, then soared by 52.0% to -$355891.0 in 2025.
  • Per Business Quant, the three most recent readings for IVF's Enterprise Value are -$355891.0 (Q3 2025), -$500000.0 (Q2 2025), and -$840407.0 (Q1 2025).